FDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot risk
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
Full Article
FDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot risk
CBS 2
0 shares
1 views
You might like
Related news coverage
FDA Restricts J&J's COVID-19 Vaccine Due To Blood Clot Risk
Newsy
Watch VideoU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing..
Advertisement
More coverage
FDA restricts Johnson & Johnson vaccine
CBS 2
It's all due to a rare, but potentially life-threatening, risk of blood clots. CBS2's John Dias explains.
-
FDA restricts J&J’s Covid-19 vaccine due to blood clot risk
Indian Express
-
Covid-19 vaccine: US FDA limits use of Johnson and Johnson due to blood clot risk
DNA
-
US FDA limits use of Johnson & Johnson Covid-19 vaccine over blood clot risk
Zee News
-
FDA Further Limits Johnson & Johnson Covid Vaccine
NYTimes.com